Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7939
-0.0161 (-1.99%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $41.10 million as of April 24, 2025. Its market cap has decreased by -18.88% in one year.
Market Cap
41.10M
Enterprise Value
-6.05M
1-Year Change
-18.88%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $41.10M, a decrease of -90.37%. That is a compound annual growth rate of -48.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 41.10M | -5.86% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.71B |
| UnitedHealth Group | 397.05B |
| Johnson & Johnson | 380.51B |
| AbbVie | 304.65B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 228.43B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |